摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-[7-(3,4-dihydroxy-5-methoxy-6,6-dimethyloxan-2-yl)oxy-4-hydroxy-8-methyl-2-oxochromen-3-yl]-4-hydroxy-3-(3-methylbut-2-enyl)benzamide

中文名称
——
中文别名
——
英文名称
N-[7-(3,4-dihydroxy-5-methoxy-6,6-dimethyloxan-2-yl)oxy-4-hydroxy-8-methyl-2-oxochromen-3-yl]-4-hydroxy-3-(3-methylbut-2-enyl)benzamide
英文别名
——
N-[7-(3,4-dihydroxy-5-methoxy-6,6-dimethyloxan-2-yl)oxy-4-hydroxy-8-methyl-2-oxochromen-3-yl]-4-hydroxy-3-(3-methylbut-2-enyl)benzamide化学式
CAS
——
化学式
C30H35NO10
mdl
——
分子量
569.6
InChiKey
UZHGFJZFJRMSOS-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.3
  • 重原子数:
    41
  • 可旋转键数:
    7
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.4
  • 拓扑面积:
    164
  • 氢给体数:
    5
  • 氢受体数:
    10

文献信息

  • Methods of treatment for bacterial infections
    申请人:President and Fellows of Harvard College
    公开号:US11191773B2
    公开(公告)日:2021-12-07
    This invention features new compositions and methods that are useful in treating a host with a Gram-negative bacterial infection. Combination therapies comprising an aminocoumarin compound and a polymyxin compound are disclosed, including certain combinations that exhibit synergistic effects. Furthermore, aminocoumarin compounds are described having altered inhibition of DNA gyrase in Gram-negative bacteria and/or the ability to target the transport proteins responsible for assembling lipopolysaccharide in the outer membrane of Gram-negative bacteria.
    本发明的特点是采用了新的组合物和方法,可用于治疗患有革兰氏阴性细菌感染的宿主。本发明公开了由氨基香豆素化合物和多粘菌素化合物组成的组合疗法,包括某些表现出协同效应的组合。此外,还描述了氨基香豆素化合物对革兰氏阴性细菌DNA回旋酶的抑制作用发生改变,和/或能够靶向负责在革兰氏阴性细菌外膜中组装脂多糖的转运蛋白。
  • METHODS OF TREATMENT FOR BACTERIAL INFECTIONS
    申请人:President and Fellows of Harvard College
    公开号:US20200163985A1
    公开(公告)日:2020-05-28
    This invention features new compositions and methods that are useful in treating a host with a Gram-negative bacterial infection. Combination therapies comprising an aminocoumarin compound and a polymyxin compound are disclosed, including certain combinations that exhibit synergistic effects. Furthermore, aminocoumarin compounds are described having altered inhibition of DNA gyrase in Gram-negative bacteria and/or the ability to target the transport proteins responsible for assembling lipopolysaccharide in the outer membrane of Gram-negative bacteria.
查看更多